Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-27 09:45:31 - browse：62183

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

WSS

WuXi Biologics execs register to lobby as Congress comes for the company

FTX founder Sam Bankman

Lessons Learned: This is why you network to find that industry job you want

Galapagos to make CAR

Free medical tuition alone isn't enough to close gaps in primary care

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

leisure time

Wikipedia

hotspot

In Memoriam: Notable people who died in 2023

Ripples from Flovent's discontinuation is killing children with asthma

What does generative AI mean for health care? We asked experts

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Psychedelics group wrestles with new pharma identity

Lilly’s weekly insulin works as well as daily products, new studies show

Wildfire smoke exposes gaps in outdoor worker protections

FTX founder Sam Bankman

Medicare proposal to cover medical devices draws a mixed reaction

Judge rejects Trump's counterclaim against E. Jean Carroll

hotspot

ALS treatment from Biogen, Ionis fails in study

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Lilly’s weekly insulin works as well as daily products, new studies show

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

In venture capital firm's success, lessons for turning crisis into profit

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

focus

entertainment

knowledge

hotspot